NCT02520921 - Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome | Biotech Hunter

Enrollment

2,485

Participants

Timeline

Start Date

June 13, 2016

Primary Completion Date

July 18, 2024

Study Completion Date

July 18, 2024

Conditions

Diabetes MellitusAcute Coronary SyndromeCoronary Artery DiseaseObesity

Interventions

DRUG

Novel strategy Aspirin

Aspirin twice a day : enteric coated enteric coated aspirin given twice a day, 100 mg in the morning and 100 mg in the evening (i.e. 200mg/day)

DRUG

Conventional strategy Aspirin

Aspirin once day: enteric coated aspirin 100 mg in the morning (i.e. 100mg/day)

Trial Locations (1)

Department of Cardiology - Lariboisiere Hospital, Paris